| Updated efficacy and safety results from a phase 1b study of the PD-1 antagonist CS1003 combined with lenvatinib (LEN) as first-line (1L) treatment in Chinese patients (pts … L Shen, Y Guo, Y Zhang, W Li, J Gong, Q Li, Z Ma, N Wang, R Su, Z Cai, ... Journal of Clinical Oncology 40 (16_suppl), e16191-e16191, 2022 | 4 | 2022 |
| Bayesian analysis for quantile smoothing spline Z Cai, D Sun Statistical Theory and Related Fields 5 (4), 346-364, 2021 | 4 | 2021 |
| Prior conditioned on scale parameter for Bayesian quantile LASSO and its generalizations Z Cai, D Sun Statistics and Its Interface 14 (4), 459-474, 2021 | 3 | 2021 |
| Bayesian Hierarchical Model for Synthesizing Registry and Survey Data on Female Breast Cancer Prevalence Q Wang, CL Schmaltz, J Jackson-Thompson, D Sun, Z He, Z Cai, H Hong arXiv preprint arXiv:2410.23580, 2024 | | 2024 |
| A composite Bayesian approach for quantile curve fitting with non-crossing constraints Q Wang, Z Cai Communications in Statistics-Theory and Methods 53 (20), 7119-7143, 2024 | | 2024 |
| Bayesian quantile group lasso for 2008-2017 Missouri cancer incidence and prevalence with multiple cancer sites Q Wang, C Schmaltz, Z Cai, J Jackson-Thompson APHA 2021 Annual Meeting and Expo, 2021 | | 2021 |
